ABSTRACT
Accurate and efficient diagnosis of potential COVID-19 patients is vital in the fight against the current pandemic. However, even the gold-standard COVID-19 test—reverse transcription polymerase chain reaction—suffers from a high false negative rate and a turnaround time of up to one week, preventing the infected from accessing the timely care they require, and impeding efforts to isolate positive cases. To address these shortcomings, this study develops a machine learning model based on the DenseNet-201 deep convolutional neural network, that can classify COVID-19 from chest radiographs in less than one minute and far more accurately than conventional tests (F1-score: 0.96; precision: 0.95; recall: 0.98). It uses a significantly larger dataset and more control classes than previously published models, demonstrating the promise of a machine learning approach for accurate and efficient COVID-19 screening. A live web application of the trained model can be accessed at https://cov2d19-classifier.herokuapp.com/.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received to conduct this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No additional IRB or ethics committee approvals were required or obtained for this study.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data is publicly available and listed in the references of the paper (references 20-27).
